Baker McKenzie advises STADA Arzneimittel AG, a leading manufacturer of high-quality pharmaceuticals, on its acquisition of Lobsor Pharmaceuticals, a Swedish-based provider of innovative therapy used for treating late-stage Parkinson’s disease.

Baker McKenzie's core deal team consists of Peder Oxhammar, Costin Mihailescu, Edvard Henriksson, Seher Budak and Maja Uppgren.

Explore Our Newsroom